"Dr. Robert Chandler Exposes Batch-Based Injuries"

A lead physician of the WarRoom/DailyClout Pfizer Documents Research Team, Dr. Robert Chandler, explains a new peer-reviewed study of 5 million Scandinavians, that shows three different outcomes, generally, based upon batch received. Is the mRNA rollout a massive ongoing experiment? Did Pfizer knowingly create three different formulas? Also: to find out what may have happened to you. Please Support Our SponsorsBirch Gold Group: "A Gold IRA from Birch Gold Group is the ultimate inflation hedge for your savings in uncertain times. To see how to protect your IRA or 401(k), get your FREE info kit on gold by texting the word 'DAILYCLOUT' to 989898."The Wellness Company: https://dailyclouthealth.comUse code DAILYCLOUT for 10% off!NativePath: "Collagen supplements help you replace what you stop producing — and the studies speak for themselves. Visit https://getnativepath.com/dailyclout for a MASSIVE 45% discount plus free shipping!"BiOptimizers: "Over 75% of the population is magnesium deficient. Nurture your mind and body with this all-natural, full-spectrum magnesium supplement. Go to https://bioptimizers.com/dailyclout and use promo code DAILYCLOUT for 10% off!"Order ‘The Pfizer Papers’ and Support Our Historic Work: https://www.skyhorsepublishing.com/the-pfizer-papers/Discover LegiSector! Stay up-to-date on issues you care about with LegiSector’s state-of-the-art summarizing capabilities and customizable portals. No researchers needed, no lobbyists, no spin. Legislation at your fingertips! Learn more at https://www.legisector.com/Blackout Coffee: "Blackout Coffee works with local co-ops and farmers to grow high-quality, delicious coffee beans. Blackout Coffee gives back to our military by sending donated coffee care packages to deployed troops." Visit https://www.blackoutcoffee.com or use promo code DAILYCLOUT20 at checkout. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit bestofdailyclout.substack.com/subscribe